Get the Daily Brief
Latest Biotech News
Parkinson’s Disease: Biomarkers and Genetic Insights
Emerging research highlights novel biomarkers and genetic factors influencing Parkinson’s disease onset, progression, and heterogeneity. Studies report elevated cerebrospinal fluid SERPIN E1...
AI and Computational Models Accelerating Drug Discovery and Disease Research
Artificial intelligence and computational modeling are increasingly transforming biotech research, from accelerating antiviral drug design against coronaviruses to enhancing antibody engineering...
Innovations in Neuroprosthetics and Brain-Computer Interfaces
Significant progress has been made in brain-computer interface (BCI) technology enabling communication and motor control for individuals with neurological impairments. Real-time neural decoding...
Breakthroughs in Plant Science and Crop Resilience
Recent advances redefine plant temperature sensing mechanisms, revealing decentralized genetic networks responsible for thermosensation, enabling design of climate-tailored crop varieties....
Drug Development and Therapeutic Advances
The biotech pipeline sees several notable developments including novel drug combinations demonstrating safety and efficacy in acute myeloid leukemia with specific genetic alterations, new...
Emerging Technologies in Biomanufacturing and Drug Screening
Novel platform technologies enhance biomanufacturing efficiency and drug screening capabilities. The collaboration between MaxCyte and Ori Biotech streamlines autologous cell therapy production,...
Environmental and Energy Innovations Addressing Climate Challenges
Innovative environmental solutions show promise in mitigating climate impacts. Dairy digesters in California effectively capture and reuse methane, reducing emissions by about 80%. In renewable...
Advances in Cancer Biology and Therapeutics
Cancer research progresses with insights into tumor plasticity, glycosaminoglycan-mediated lipoprotein uptake protecting tumors from ferroptosis, and novel gene therapy strategies targeting rare...
BioNTech buys CureVac in $1.25B stock pact ending mRNA dispute
BioNTech confirmed the acquisition of CureVac in a $1.25 billion all-stock deal that resolves ongoing mRNA patent litigation while enhancing its oncology pipeline. The agreement includes CureVac’s...
Instant voice-synthesis neuroprosthesis restores expressive speech
A pioneering brain-computer interface enabled a man with ALS to speak and sing naturally by synthesizing voice nearly instantaneously from neural signals, restoring expressive communication with...
ADC Therapeutics shutters UK R&D, cuts workforce by 30%
After discontinuing multiple clinical-stage programs due to poor efficacy, ADC Therapeutics is closing its UK research site and laying off 30% of staff to focus efforts on approved therapies and...
BioNTech Acquires CureVac in $1.25 Billion mRNA Deal
BioNTech has struck an all-stock agreement to acquire CureVac, a fellow German mRNA vaccine and cancer immunotherapy developer, for approximately $1.25 billion. The deal settles ongoing patent...
FDA Clears UroGen’s Zusduri Bladder Cancer Hydrogel
The FDA approved UroGen Pharma’s intravesical hydrogel treatment, Zusduri (formerly UGN-102), for recurrent low-grade, intermediate-risk non-muscle invasive bladder cancer despite a narrowly...
Nuvation Bio’s Ibtrozi Wins FDA Nod for ROS1-Positive Lung Cancer
Nuvation Bio received FDA approval for Ibtrozi (taletrectinib), a next-generation oral inhibitor targeting ROS1-positive non-small cell lung cancer (NSCLC), a disease subset with limited existing...
Artificial Intelligence Accelerates Drug Discovery and Protein Engineering
Innovative AI applications are reshaping drug development and biologics characterization. Infinimmune launched GLIMPSE-1, a protein language model trained using human antibody sequences, to...
Advanced Brain-Computer Interface Enables Real-Time Voice Synthesis
Researchers have developed a brain-computer interface (BCI) capable of nearly instantaneous voice synthesis from neural signals with natural speech features like intonation and singing. Implanted...
Rapid Organ-Scale Synthetic Vasculature Designs Aid 3D Bioprinting
A new computational platform rapidly generates complex vasculature trees at organ scale within minutes, a 230-fold speed increase over previous methods. Developed by Sexton and colleagues, it...
New AI-Enabled Broad-Spectrum Coronavirus Antiviral Developed
An interdisciplinary team led by Harvard’s Wyss Institute used AI-driven dynamic molecular modeling to develop bemcentinib, an FDA-approved oral drug repurposed to target coronaviruses...
Cancer Plasticity Atlas to Drive Therapy Response Prediction
The Wellcome Sanger Institute, Helmholtz Munich, and Parse Biosciences announced a collaborative project to build a large single-cell atlas of cancer plasticity. By analyzing hundreds of millions...
New Insights into Parkinson’s Disease Subtypes and Diagnostics
Multiple studies advance understanding of Parkinson's disease biology and diagnostics. Research into genetic variant severity and polygenic backgrounds informs penetrance and progression risk for...